Colorectal Cancer Screening Market by Type and Application- Global Industry Analysis & Forecast to 2027

Published On : March 2021 Pages : 158 Category: Pharma & Healthcare Report Code : HC0316689

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Colorectal Cancer Screening Market By Type (Stool-based tests, Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Others) and Application (Hospitals, Specialty Clinics, Ambulatory Surgery Centres, Diagnostic Centers, Others)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Colorectal Cancer Screening Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Colorectal Cancer Screening help find cancer at an early stage. When abnormal tissue or cancer is found early, it may be easier to treat. By the time symptoms appear, cancer may have begun to spread.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Colorectal Cancer Screening Marketand estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • Exact Sciences Corp.
  • Eiken Chemical
  • AlereInc
  • Hemosure
  • Epigenomics AG
  • Clinical Genomics
  • Novigenix SA
  • Beckman Coulter
  • Quidel Corporation

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2021 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Colorectal Cancer Screening Market , ByType, Estimates and Forecast, 2017-2027 ($Million)

o    Stool-based tests

o    Colonoscopy

o    CT Colonography

o    Flexible Sigmoidoscopy

o    Others

·         Colorectal Cancer Screening Market , ByApplication, Estimates and Forecast, 2017-2027 ($Million)

o    Hospitals

o    Specialty Clinics

o    Ambulatory Surgery Centres

o    Diagnostic Centers

o    Others

·         Colorectal Cancer Screening Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    Exact Sciences Corp.

o    Eiken Chemical

o    AlereInc

o    Hemosure

o    Epigenomics AG

o    Clinical Genomics

o    Novigenix SA

o    Beckman Coulter

o    Quidel Corporation

·         Colorectal Cancer Screening Market , By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Colorectal Cancer Screening Market , By Country

o    U.S. Colorectal Cancer Screening Market

o    Canada Colorectal Cancer Screening Market

o    Mexico Colorectal Cancer Screening Market

o    Europe

§  Europe Colorectal Cancer Screening Market , By Country

o    UK Colorectal Cancer Screening Market

o    Germany Colorectal Cancer Screening Market

o    France Colorectal Cancer Screening Market

o    Russia Colorectal Cancer Screening Market

o    Italy Colorectal Cancer Screening Market

o    Rest of Europe Colorectal Cancer Screening Market

o    Asia-Pacific

§  Asia-Pacific Colorectal Cancer Screening Market , By Country

o    China Colorectal Cancer Screening Market

o    Japan Colorectal Cancer Screening Market

o    South Korea Colorectal Cancer Screening Market

o    India Colorectal Cancer Screening Market

o    Southeast Asia Colorectal Cancer Screening Market

o    Rest of Asia-Pacific Colorectal Cancer Screening Market

o    South America

§  South America Colorectal Cancer Screening Market

o    Brazil Colorectal Cancer Screening Market

o    Argentina Colorectal Cancer Screening Market

o    Columbia Colorectal Cancer Screening Market

o    Rest of South America Colorectal Cancer Screening Market

o    Middle East and Africa

§  Middle East and Africa Colorectal Cancer Screening Market

o    Saudi Arabia Colorectal Cancer Screening Market

o    UAE Colorectal Cancer Screening Market

o    Egypt Colorectal Cancer Screening Market

o    Nigeria Colorectal Cancer Screening Market

o    South Africa Colorectal Cancer Screening Market

o    TurkeyColorectal Cancer Screening Market

o    Rest of MEA Colorectal Cancer Screening Market

 

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Colorectal Cancer Screening  Market, By Type

5.1.     Introduction

5.2.     Global Colorectal Cancer Screening  Revenue and Market Share by Type (2017-2021)

5.2.1.  Global Colorectal Cancer Screening  Revenue and Revenue Share by Type (2017-2021)

5.3.     Stool-based tests

5.3.1.  Global Stool-based tests Revenue and Growth Rate (2017-2021)

5.4.     Colonoscopy

5.4.1.  Global Colonoscopy Revenue and Growth Rate (2017-2021)

5.5.     CT Colonography

5.5.1.  Global CT Colonography Revenue and Growth Rate (2017-2021)

5.6.     Flexible Sigmoidoscopy

5.6.1.  Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2021)

5.7.     Others

5.7.1.  Global Others Revenue and Growth Rate (2017-2021)

6.       Colorectal Cancer Screening  Market, By Applications

6.1.     Introduction

6.2.     Global Colorectal Cancer Screening  Revenue and Market Share by Applications (2017-2021)

6.2.1.  Global Colorectal Cancer Screening  Revenue and Revenue Share by Applications (2017-2021)

6.3.     Hospitals

6.3.1.  Global Hospitals Revenue and Growth Rate (2017-2021)

6.4.     Specialty Clinics

6.4.1.  Global Specialty Clinics Revenue and Growth Rate (2017-2021)

6.5.     Ambulatory Surgery Centres

6.5.1.  Global Ambulatory Surgery Centres Revenue and Growth Rate (2017-2021)

6.6.     Diagnostic Centers

6.6.1.  Global Diagnostic Centers Revenue and Growth Rate (2017-2021)

6.7.     Others

6.7.1.  Global Others Revenue and Growth Rate (2017-2021)

7.       Colorectal Cancer Screening  Market, By Region

7.1.     Introduction

7.2.     Global Colorectal Cancer Screening  Revenue and Market Share by Regions

7.2.1.  Global Colorectal Cancer Screening  Revenue by Regions (2017-2021)

7.3.     North America Colorectal Cancer Screening  by Countries

7.3.1.  North America Colorectal Cancer Screening  Revenue and Growth Rate (2017-2021)

7.3.2.  North America Colorectal Cancer Screening  Revenue (Million USD) by Countries (2017-2021)

7.3.3.  United States

7.3.3.1.  United States Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.4.  Canada

7.3.4.1.  Canada Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.3.5.  Mexico

7.3.5.1.  Mexico Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.     Europe Colorectal Cancer Screening  by Countries

7.4.1.  Europe Colorectal Cancer Screening  Revenue and Growth Rate (2017-2021)

7.4.2.  Europe Colorectal Cancer Screening  Revenue (Million USD) by Countries (2017-2021)

7.4.3.  Germany

7.4.3.1.  Germany Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.4.  France

7.4.4.1.  France Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.5.  UK

7.4.5.1.  UK Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.6.  Russia

7.4.6.1.  Russia Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.7.  Italy

7.4.7.1.  Italy Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.     Asia-Pacific Colorectal Cancer Screening  by Countries

7.5.1.  Asia-Pacific Colorectal Cancer Screening  Revenue and Growth Rate (2017-2021)

7.5.2.  Asia-Pacific Colorectal Cancer Screening  Revenue (Million USD) by Countries (2017-2021)

7.5.3.  China

7.5.3.1.  China Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.4.  Japan

7.5.4.1.  Japan Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.5.  Korea

7.5.5.1.  Korea Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.6.  India

7.5.6.1.  India Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.     South America Colorectal Cancer Screening  by Countries

7.6.1.  South America Colorectal Cancer Screening  Revenue and Growth Rate (2017-2021)

7.6.2.  South America Colorectal Cancer Screening  Revenue (Million USD) by Countries (2017-2021)

7.6.3.  Brazil

7.6.3.1.  Brazil Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.4.  Argentina

7.6.4.1.  Argentina Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.5.  Columbia

7.6.5.1.  Columbia Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.     Middle East and Africa Colorectal Cancer Screening  by Countries

7.7.1.  Middle East and Africa Colorectal Cancer Screening  Revenue and Growth Rate (2017-2021)

7.7.2.  Middle East and Africa Colorectal Cancer Screening  Revenue (Million USD) by Countries (2017-2021)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.5.  Egypt

7.7.5.1.  Egypt Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.7.  South Africa

7.7.7.1.  South Africa Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.8.  Turkey

7.7.8.1.  Turkey Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2017-2021)

8.       Company Profiles

8.1.     Exact Sciences Corp.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Eiken Chemical

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Alere Inc

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Hemosure

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Epigenomics AG

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Clinical Genomics

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Novigenix SA

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Beckman Coulter

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Quidel Corporation

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

9.       Colorectal Cancer Screening  Market Forecast (2022-2027)

9.1.     Global Colorectal Cancer Screening  Revenue (Millions USD) and Growth Rate (2022-2027)

9.2.     Colorectal Cancer Screening  Market Forecast by Regions (2022-2027)

9.2.1.  North America Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.1.1.  United States Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.1.2.  Canada Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.1.3.  Mexico Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.  Europe Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.1.  Germany Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.2.  France Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.3.  UK Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.4.  Russia Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.5.  Italy Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.2.6.  Rest of Europe Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.  Asia-Pacific Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.1.  China Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.2.  Japan Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.3.  Korea Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.4.  India Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.5.  Southeast Asia Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.3.6.  Rest of Asia-Pacific Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.4.  South America Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.4.1.  Brazil Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.4.2.  Argentina Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.4.3.  Columbia Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.4.4.  Rest of South America Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.  Middle East and Africa Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.1.  Saudi Arabia Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.2.  United Arab Emirates Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.3.  Egypt Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.4.  Nigeria Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.5.  South Africa Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.6.  Turkey Colorectal Cancer Screening  Market Forecast (2022-2027)

9.2.5.7.  Rest of Middle East and Africa Colorectal Cancer Screening  Market Forecast (2022-2027)

9.3.     Colorectal Cancer Screening  Market Forecast by Type (2022-2027)

9.3.1.  Colorectal Cancer Screening  Forecast by Type (2022-2027)

9.3.2.  Colorectal Cancer Screening  Market Share Forecast by Type (2022-2027)

9.4.     Colorectal Cancer Screening  Market Forecast by Applications (2022-2027)

9.4.1.  Colorectal Cancer Screening  Forecast by Applications (2022-2027)

9.4.2.  Colorectal Cancer Screening  Market Share Forecast by Applications (2022-2027)


List of Tables

List of Tables and Figures:

Figure United States Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Colorectal Cancer Screening Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Colorectal Cancer Screening Revenue and Revenue Share by Type (2017-2019)
Figure Global Stool-based tests Revenue and Growth Rate (2017-2019)
Figure Global Colonoscopy Revenue and Growth Rate (2017-2019)
Figure Global CT Colonography Revenue and Growth Rate (2017-2019)
Figure Global Flexible Sigmoidoscopy Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Colorectal Cancer Screening Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Specialty Clinics Revenue and Growth Rate (2017-2019)
Figure Global Ambulatory Surgery Centres Revenue and Growth Rate (2017-2019)
Figure Global Diagnostic Centers Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Colorectal Cancer Screening Revenue by Regions (2017-2019)
Figure North America Colorectal Cancer Screening Growth Rate (2017-2019)
Figure North America Colorectal Cancer Screening Revenue and Growth Rate (2017-2019)
Figure North America Colorectal Cancer Screening by Countries (2017-2019)
Figure North America Colorectal Cancer Screening Revenue (Million USD) by Countries (2017-2019)
Figure United States Colorectal Cancer Screening Growth Rate (2017-2019)
Figure United States Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Canada Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Mexico Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Europe Colorectal Cancer Screening Revenue and Growth Rate (2017-2019)
Figure Europe Colorectal Cancer Screening by Countries (2017-2019)
Figure Europe Colorectal Cancer Screening Revenue (Million USD) by Countries (2017-2019)
Figure Germany Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Germany Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Colorectal Cancer Screening Growth Rate (2017-2019)
Figure France Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Colorectal Cancer Screening Growth Rate (2017-2019)
Figure UK Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Russia Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Italy Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Rest of Europe Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Asia-Pacific Colorectal Cancer Screening Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Colorectal Cancer Screening by Countries (2017-2019)
Figure Asia-Pacific Colorectal Cancer Screening Revenue (Million USD) by Countries (2017-2019)
Figure China Colorectal Cancer Screening Growth Rate (2017-2019)
Figure China Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Japan Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Korea Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Colorectal Cancer Screening Growth Rate (2017-2019)
Figure India Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Southeast Asia Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Colorectal Cancer Screening Growth Rate (2017-2019)
Figure South America Colorectal Cancer Screening Revenue and Growth Rate (2017-2019)
Figure South America Colorectal Cancer Screening by Countries (2017-2019)
Figure South America Colorectal Cancer Screening Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Brazil Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Argentina Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Columbia Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Rest of South America Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Middle East and Africa Colorectal Cancer Screening Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Colorectal Cancer Screening by Countries (2017-2019)
Figure Middle East and Africa Colorectal Cancer Screening Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Saudi Arabia Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Colorectal Cancer Screening Growth Rate (2017-2019)
Figure United Arab Emirates Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Egypt Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Nigeria Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Colorectal Cancer Screening Growth Rate (2017-2019)
Figure South Africa Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Turkey Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Colorectal Cancer Screening Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2017-2019)
Table Exact Sciences Corp. Colorectal Cancer Screening Financial Overview
Table Eiken Chemical Colorectal Cancer Screening Financial Overview
Table Alere Inc Colorectal Cancer Screening Financial Overview
Table Hemosure Colorectal Cancer Screening Financial Overview
Table Epigenomics AG Colorectal Cancer Screening Financial Overview
Table Clinical Genomics Colorectal Cancer Screening Financial Overview
Table Novigenix SA Colorectal Cancer Screening Financial Overview
Table Beckman Coulter Colorectal Cancer Screening Financial Overview
Table Quidel Corporation Colorectal Cancer Screening Financial Overview
Figure Global Colorectal Cancer Screening Revenue (Millions USD) and Growth Rate (2019-2027)
Table Colorectal Cancer Screening Market Forecast by Regions (2019-2027)
Figure North America Colorectal Cancer Screening Market Forecast (2019-2027)
Figure United States Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Canada Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Mexico Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Europe Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Germany Colorectal Cancer Screening Market Forecast (2019-2027)
Figure France Colorectal Cancer Screening Market Forecast (2019-2027)
Figure UK Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Russia Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Italy Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Rest of Europe Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Asia-Pacific Colorectal Cancer Screening Market Forecast (2019-2027)
Figure China Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Japan Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Korea Colorectal Cancer Screening Market Forecast (2019-2027)
Figure India Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Southeast Asia Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Colorectal Cancer Screening Market Forecast (2019-2027)
Figure South America Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Brazil Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Argentina Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Columbia Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Rest of South America Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Middle East and Africa Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Saudi Arabia Colorectal Cancer Screening Market Forecast (2019-2027)
Figure United Arab Emirates Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Egypt Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Nigeria Colorectal Cancer Screening Market Forecast (2019-2027)
Figure South Africa Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Turkey Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Colorectal Cancer Screening Market Forecast (2019-2027)
Figure Global Colorectal Cancer Screening Forecast by Type (2019-2027)
Figure Global Colorectal Cancer Screening Market Share Forecast by Type (2019-2027)
Figure Global Colorectal Cancer Screening Forecast by Type (2019-2027)
Figure Global Colorectal Cancer Screening Forecast by Applications (2019-2027)
Figure Global Colorectal Cancer Screening Market Share Forecast by Applications (2019-2027)
Figure Global Colorectal Cancer Screening Forecast by Applications (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country